Results 221 to 230 of about 832,259 (254)

Quantitative assessment of extravasation of IL-15-secreting MSLN-CAR-NK-92 cells using tumor transparency imaging. [PDF]

Theranostics
Hong S, Moon D, Hwang S, Lee M, Cho D, Song JM.   +5 more
europepmc   +1 more source

Neutrophils: Heterogeneity, Biology, Diseases, and Therapeutic Strategies

MedComm, Volume 7, Issue 11, November 2026.
Neutrophils exhibit remarkable functional plasticity and play dual roles in tissue protection and disease progression. This review summarizes their key biological functions and highlights the shift from conventional broad‐spectrum interventions to neutrophil‐based drug delivery systems.
Yibing Zhang, Siwen Wu, Yusi Wang, Die Hu, Li Yang   +4 more
wiley   +1 more source

CAR-NK cell for gynecological cancers: immune microenvironment remodeling and immunotherapeutic strategies. [PDF]

Front Immunol
Huang M, Wang S, Huang H, Li L, Wang T.
europepmc   +1 more source

Liver Injury Repair and Regeneration: Molecular Mechanisms and Therapeutic Targets

MedComm, Volume 7, Issue 11, November 2026.
This review outlines the spatiotemporal framework of liver injury repair and regeneration, orchestrated by molecular signaling, multicellular niche crosstalk, metabolic reprogramming, and interorgan communication. Post‑injury regenerative cascades (initiation, proliferation, termination) rely on crosstalk between hepatocytes, Kupffer cells, hepatic ...
Mingyue Pan, Ni An, Yutian Feng, Yuelei Hu, Chongqin Pan, Yuxin Su, Yuanzheng Huang, Tanqing Long, Qi Wang, Qingru Song, Pengfei Li, Xiaomeng Li, Wenzhen Yin, Zhiyuan Hu, Xiaoxuan Liu, Juan Liu   +15 more
wiley   +1 more source

Non-viral targeted integration at the CISH locus enables CAR-NK cell engineering with enhanced anti-tumor activity. [PDF]

Mol Ther Oncol
Wang J, Sun Y, Starzyk J, Wang F, Dong X, Shan R, He X, Xie K, Xie G, Wu H.   +9 more
europepmc   +1 more source

Efficient, fratricide free non-viral engineering of CD70-targeted CAR NK cells for hematologic and solid tumor immunotherapy. [PDF]

Mol Ther Adv
Chang JW, Krueger J, Folsom TD, Skeate JG, Stelljes EM, Lahr WS, Slipek NJ, Pomeroy EJ, Webber BR, Moriarity BS.   +9 more
europepmc   +1 more source

Engineering Bi-Specific CAR-NK Cells to Restore Antibody-Dependent Cellular Cytotoxicity in Solid Tumors. [PDF]

Cells
Chung JY, Kim JE, Cha D, Lee HJ, Verhoeyen E, An HJ, Park JE.   +6 more
europepmc   +1 more source

Dual CAR-NK cells targeting PD-L1 and ErbB2 (HER2) exhibit cooperative CAR signaling and counteract solid tumor heterogeneity. [PDF]

J Exp Clin Cancer Res
Freudenberg-Jahn K, Ben-Horin I, Murali Shankar N, Schuldt M, Ortiz-Montero P, Loureiro LR, Rackwitz W, Opitz C, Krutz L, Breither T, Oberoi P, Häcker A, Jäger D, Kuhlmann JD, Wimberger P, Künzel SR, Hölig K, Feldmann A, Bachmann M, Wels WS, Tonn T, Eitler J.   +21 more
europepmc   +1 more source

Evaluation of Efficacy and Safety of Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cells in Breast Cancer: A Systematic Review and Meta-Analysis. [PDF]

Cancers (Basel)
Ahmed N, Jabeen J, Noor S, Rehman M, Tahseen S, Qamar A, Anas M, Khalid MM, Li T, Lyu L, Hu Z.   +10 more
europepmc   +1 more source

CAR NK cell therapy for solid tumors: potential and challenges. [PDF]

Antib Ther
Yu Y, Ho M.
europepmc   +1 more source